Meet Dr. Matt Dawson
Dr. Dawson developed a deep interest in genomics and epigenetics, realizing their potential to revolutionize our understanding of health and longevity. As the CEO of TruDiagnostic, Dr. Dawson leads the company’s mission to advance the science of epigenetics and provide groundbreaking insights into aging and disease prevention. His dedication to optimizing human performance, which began with his personal focus on fitness and nutrition, has evolved into a professional pursuit of harnessing epigenetic data to extend health span and improve overall well-being.
Award Winning Innovator
Won national awards in education and innovation.
Published Author
Published over 2 dozen peer reviewed journal articles, and authored 2 textbooks.
Founder of Infinite Epigenetics
The most scientifically advanced longevity & preventative health company.
Podcast & App Creator
Creator of two educational podcasts and mobile app.
Bridging the gap between epigenetic research and practical healthcare applications
Dr. Matthew Dawson completed his residency at The University of Utah, where he served as both chief resident and fellow. After practicing medicine and serving as an associate professor for seven years, Dr. Dawson developed a deep interest in genomics and epigenetics, realizing their potential to revolutionize our understanding of health and longevity.
As the CEO, TruDiagnostic is at the forefront of epigenetic testing and research, empowering individuals and researchers with actionable information about biological aging, disease susceptibility, and personalized health strategies. Dr. Dawson’s passion for using cutting-edge science to impact lives is evident in his efforts to bridge the gap between epigenetic research and practical healthcare applications. He has trained physicians and healthcare providers in the importance of epigenetic markers, ensuring that TruDiagnostic’s work continues to push the boundaries of what’s possible in preventive health. He regularly shares insights through public speaking and educational platforms, advocating for the role of epigenetics in reshaping healthcare.